Fun to think about. Post from FB: Michael Andre
Post# of 152657

Michael Andrew Brown
Rising contributor
·
???? $1 Scenario — What Has to Happen:
1. Poster lands hard (May 15):
• Shows survival tail stratified by dose
• Confirms 700mg + combo therapy = long-term survivors
• Mentions biomarker strategy (CTCs, LifeTracDx)
• Points to a next trial or FDA engagement
2. Same-day PR from CytoDyn:
• Reinforces poster clarity
• Hints at regulatory dialogue or new study
• Uses strong language like “breakthrough,” “synergy,” “next phase”
3. Volume rips above 30–40M shares Thursday/Friday
That’s your breakout setup. Under those conditions, yes, $1 is on the table — possibly intraday Thursday or a Friday spike.

